CD4 and lymphoma: Although Morimura et al. attempted to address the role of CD4+ T cells after CVI988 immunization by depleting CD4+ T cells, their role has not been determined in vaccine-induced protective immunity [112, 113], possibly because depletion of CD4+ T cells may also result in the deficiency of lymphoma cells that are transformed from MDV-infected CD4+ T cells after challenge.